ArticleDiagnostic pathology2024

Interlaboratory variability of HER2 fluorescence in situ hybridization testing in breast cancer: results of a multicenter proficiency-testing ring study in China.

Rongxue Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.